TBH I think you are right about IMU being exactly where it should be, we've got 3 lead IPs all in phase 1 each being easily 3-5 years before any form of commercialisation. these are the exact same levels we were at when Her-vaxx was in phase 1, and the market is reacting the same. positive results come out and it goes backwards - either the results were already priced in and profit taking occurred or the results weren't the blockbuster investors were expecting. that being said, getting 3 drugs out of phase 1 and showing the market real results could see the exact same reaction the market had for Her-Vaxx & co. where the SP shot up exponentially. T/A view at the moment is totally screwed and F/A is being dragged down until real results are released. and to be honest it's yours and others time to rip on the company which is probably warranted until IMU walk the walk, but the results will come and there is absolutely nothing on the market or otherwise to say these results are going to be negative.
IMU Price at posting:
2.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)